Coya Therapeutics, Inc.

US$2.99As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:COYAHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (11.26%)
Div yield —
ROE (60.54%)
Biotechnology
Beta (5Y) 0.70
PE TTM —
TSR TTM (52.69%)
Mkt cap US$70.14M
ROIC (36.41%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.92
(2.34%)
(53.58%)
Hold 2|10|2|11|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.04
0.04
14.82%
6.95%
20.26%
20.57%
Revenue$M
5.218
5.417
5.564
5.706
1.60%
0.89%
5.78%
8.54%
Peers (US$70.14M)
Cap (US$)
PE
71.86M
—
Capital
TTM
5Y
10Y
Leveragex
1.554
0.265
0.267
EBIT/Intx
1.132
0.314
0.240
Own earn%
6.58
18.17
18.38
Sh yield%
20.78
33.53
33.55
Owners
Insiders/Inst%
9.88
50.70
Short interest%
0.56
SBC / revenue%
0.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
12–19
$1 testx
—
Incr. ROIC%
2